JP2020534336A5 - - Google Patents

Download PDF

Info

Publication number
JP2020534336A5
JP2020534336A5 JP2020516814A JP2020516814A JP2020534336A5 JP 2020534336 A5 JP2020534336 A5 JP 2020534336A5 JP 2020516814 A JP2020516814 A JP 2020516814A JP 2020516814 A JP2020516814 A JP 2020516814A JP 2020534336 A5 JP2020534336 A5 JP 2020534336A5
Authority
JP
Japan
Prior art keywords
group
membered
compound
alkyl
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020516814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020534336A (ja
JP7548814B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2018/106768 external-priority patent/WO2019057123A1/zh
Publication of JP2020534336A publication Critical patent/JP2020534336A/ja
Publication of JP2020534336A5 publication Critical patent/JP2020534336A5/ja
Application granted granted Critical
Publication of JP7548814B2 publication Critical patent/JP7548814B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020516814A 2017-09-20 2018-09-20 Ｉｄｏ阻害剤および／またはｉｄｏ－ｈｄａｃ二重阻害剤としての多環式化合物 Active JP7548814B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN201710854520 2017-09-20
CN201710854520.2 2017-09-20
CN201711397888 2017-12-21
CN201711397888.7 2017-12-21
CN201810119324 2018-02-06
CN201810119324.5 2018-02-06
PCT/CN2018/106768 WO2019057123A1 (zh) 2017-09-20 2018-09-20 作为ido抑制剂和/或ido-hdac双重抑制剂的多环化合物

Publications (3)

Publication Number Publication Date
JP2020534336A JP2020534336A (ja) 2020-11-26
JP2020534336A5 true JP2020534336A5 (https=) 2021-11-04
JP7548814B2 JP7548814B2 (ja) 2024-09-10

Family

ID=65810056

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020516814A Active JP7548814B2 (ja) 2017-09-20 2018-09-20 Ｉｄｏ阻害剤および／またはｉｄｏ－ｈｄａｃ二重阻害剤としての多環式化合物

Country Status (5)

Country Link
US (1) US11266640B2 (https=)
EP (1) EP3686196B1 (https=)
JP (1) JP7548814B2 (https=)
CN (1) CN109843872B (https=)
WO (1) WO2019057123A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019028440A1 (en) 2017-08-04 2019-02-07 Skyhawk Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MODULATING SPLICING
WO2019078968A2 (en) * 2017-10-18 2019-04-25 Angex Pharmaceutical, Inc. CYCLIC COMPOUNDS AS IMMUNOMODULATORS
CN110156674A (zh) * 2018-02-13 2019-08-23 中国科学院上海有机化学研究所 一种作为吲哚胺-2,3-双加氧酶抑制剂的螺环化合物
CN110357813A (zh) * 2018-04-09 2019-10-22 信达生物制药(苏州)有限公司 一种新型吲哚胺2,3-双加氧酶抑制剂及其制备方法和用途
GEP20227433B (en) 2018-04-26 2022-10-25 Pfizer 2-amino-pyridine or 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors
CN116574105B (zh) 2018-09-27 2025-10-10 深圳微芯生物科技股份有限公司 具有吲哚胺-2,3-双加氧酶抑制活性的喹啉衍生物
WO2020163248A1 (en) 2019-02-04 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
EP3920915A4 (en) 2019-02-05 2022-10-05 Skyhawk Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MODULATING SPLICE
CN114126613A (zh) 2019-02-05 2022-03-01 斯基霍克疗法公司 用于调节剪接的方法和组合物
WO2020163544A1 (en) 2019-02-06 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
CN113661162A (zh) 2019-02-06 2021-11-16 斯基霍克疗法公司 用于调节剪接的方法和组合物
CN111909107B (zh) * 2019-05-10 2023-02-03 药康众拓(江苏)医药科技有限公司 Ido/hdac双重抑制剂及其药物组合物和应用
AU2020384481B2 (en) * 2019-11-12 2025-12-11 Nammi Therapeutics, Inc. Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL133960A0 (en) 1997-08-15 2001-04-30 Pfizer Prod Inc 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives
MY145722A (en) * 2000-04-27 2012-03-30 Abbott Lab Diazabicyclic central nervous system active agents
EP1177792A3 (en) 2000-07-27 2002-10-23 Pfizer Products Inc. Dopamine D4 Ligands for the treatment of novelty-seeking disorders
WO2003070244A1 (en) 2002-02-22 2003-08-28 Abbott Laboratories Antagonist of melanin concentrating hormone and their uses
US7435830B2 (en) * 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
US8415354B2 (en) 2004-04-29 2013-04-09 Abbott Laboratories Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
JP2008510726A (ja) * 2004-08-20 2008-04-10 エントレメッド インコーポレイテッド プロテイナーゼ活性化受容体アンタゴニストを含む組成物および方法
GB0510204D0 (en) * 2005-05-19 2005-06-22 Chroma Therapeutics Ltd Enzyme inhibitors
AR069126A1 (es) * 2007-10-31 2009-12-30 Janssen Pharmaceutica Nv Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
FR2924343A1 (fr) * 2007-12-04 2009-06-05 Palumed Sa Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique.
FR2945533B1 (fr) * 2009-05-12 2011-05-27 Sanofi Aventis Derives de cyclopenta°c!pyrrolyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
AU2012264651A1 (en) * 2011-06-02 2013-12-12 Intervet International B.V. Imidazole derivatives
PT2796460T (pt) * 2011-12-21 2018-11-05 Shanghai hengrui pharmaceutical co ltd Derivado pirrole de anel heteroarilo de seis membros, método de preparação do mesmo e suas utilizações médicas
WO2014152018A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydrocyclopentapyrroles, their preparation and use
WO2014151444A1 (en) * 2013-03-14 2014-09-25 Abbvie Inc. Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
US9796708B2 (en) 2013-03-14 2017-10-24 Abbvie Inc. Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors
WO2015132799A2 (en) * 2014-02-03 2015-09-11 Cadila Healthcare Limited Novel heterocyclic compounds
RU2016149812A (ru) 2014-06-06 2018-07-17 Флексус Байосайенсиз, Инк. Иммунорегулирующие средства
UY36390A (es) * 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
UY36391A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
BR112017008809A2 (pt) 2014-11-05 2017-12-19 Flexus Biosciences Inc agentes imunorreguladores
WO2016115463A1 (en) * 2015-01-15 2016-07-21 Whitehead Institute For Biomedical Research Inhibitors of phosphoglycerate dehydrogenase (phgdh) and uses thereof
CA2991224A1 (en) 2015-07-02 2017-01-05 buildpulse, Inc. Advanced identification and classification of sensors and other points in a building automation system
WO2017007756A1 (en) * 2015-07-06 2017-01-12 Rodin Therapeutics, Inc Hetero-halo inhibitors of histone deacetylase
CN107001271B (zh) 2015-08-07 2019-05-10 江苏恒瑞医药股份有限公司 羟基脒类衍生物、其制备方法及其在医药上的应用
CN106478607B (zh) * 2015-08-28 2019-05-24 广东东阳光药业有限公司 取代的杂芳基化合物及其组合物和用途
JP2018527362A (ja) * 2015-09-11 2018-09-20 サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． 置換されたヘテロアリール化合物および使用方法
AU2016333855A1 (en) * 2015-10-09 2018-04-26 AbbVie S.à.r.l. Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and their use
WO2017097671A1 (de) 2015-12-10 2017-06-15 Bayer Pharma Aktiengesellschaft Substituierte perhydropyrrolo[3,4-c]pyrrol-derivate und ihre verwendung
US10076522B2 (en) 2016-05-04 2018-09-18 Motif BioSciences Inc. Systems and methods for treating bacterial infection
WO2017192844A1 (en) 2016-05-04 2017-11-09 Bristol-Myers Squibb Company Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
WO2017192840A1 (en) 2016-05-04 2017-11-09 Bristol-Myers Squibb Company Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
CN106916164A (zh) 2017-03-06 2017-07-04 中国药科大学 噻唑并嘧啶酮类ido1抑制剂及其医药用途
CN110540521A (zh) * 2018-05-28 2019-12-06 北京诺诚健华医药科技有限公司 八氢戊搭烯类化合物、其制备方法及其在医药学上的应用

Similar Documents

Publication Publication Date Title
JP2020534336A5 (https=)
ES2626983T3 (es) Derivado de morfinano
CN1140528C (zh) 制备除草剂衍生物的方法
RU2009105669A (ru) Способ получения 3-замещенных 2-амино-5-галогенбензамидов
TW202227389A (zh) 新穎化合物
BR112013026466A2 (pt) derivados de ácido 3-fenilpropiônico ramificados e o seu uso
RU2010101611A (ru) Полициклические производные гуанина и способы их применения
WO2015033974A1 (ja) スピロオキシインドール誘導体の製造方法
JP2015524447A (ja) Ｎ−置換ピラゾロ［３，４−ｄ］ピリミジノン類化合物、その製造方法及びその使用
PT97329A (pt) Processo para a preparacao de 2-isoxazolinas e isoxazois substutuidos nas posicoes 3,5, e de composicoes farmaceuticas que so contem
WO2017029362A1 (en) Asymmetric bisamidation of malonic ester derivatives
IL323810A (en) Synthesis of ras inhibitors
AR032433A1 (es) Proceso para la preparacion de un isomero de anillo de 5 miembros 3-sustituido y compuestos intermediarios utiles en el mismo
KR20130090360A (ko) 물 또는 다양한 산을 첨가제로 이용한 새로운 마이클-첨가 반응을 통하여 화합물을 제조하는 방법
AU2019296173B2 (en) Benzimidazole derivatives and use thereof as IDH1 inhibitors
JP2024516199A (ja) バルベナジンの合成方法
Kim et al. L-Tartaric acid as a new chiral auxiliary for asymmetric synthesis of piperazinones, morpholinones, dihydroquinoxalinones and dihydrobenzoxazinones
TW200403222A (en) Process for the preparation of amino-pyrrolidine derivatives
ES2798324B2 (es) Derivados de 1,3-oxazin-2-onas que incorporan en su estructura un átomo de bromo, procedimiento de obtención y uso
RU2010105978A (ru) Производные фуранозы
US6423843B1 (en) Enantiomerically pure substituted oxaaza compounds, salts of the same, and processes for the preparation of both
Cadwallader Epimeric L-Proline Derived Imidazolone Chiral Auxiliaries for the Stereoselective Alkylative Birch Reduction of Aromatic Esters and Benzonitriles
Wang et al. Absolute configurations and CD spectra of axially chiral biphenyls prepared in a facile manner by crystallization‐induced configuration transformation
JPWO2012070509A1 (ja) 含窒素複素環の製造方法
EA040879B1 (ru) Производные бензимидазола и их применение в качестве ингибиторов idh1